Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Claudia D.C. Wyrepkowski
Nanoscaled Hydrated Antimony (V) Oxide as a New Approach to First-Line Antileishmanial Drugs
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Related publications
Syntheses of Organic Antimony Compounds as Anti-Kala-Azar Drugs. V
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
Flow Analysis-Hydride Generation-Gas Phase Derivative Molecular Absorption Spectrophotometric Determination of Antimony in Antileishmanial Drugs
Quimica Nova
Chemistry
First-Line Drugs for Hypertension
Cochrane Database of Systematic Reviews
A Novel Organotellurium Compound (RT-01) as a New Antileishmanial Agent
Korean Journal of Parasitology
Parasitology
Infectious Diseases
Endovascular Treatment as First Line Approach for Infrarenal Aortic Occlusive Disease
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation
JAMA - Journal of the American Medical Association
Medicine
Sanger Sequencing as a First-Line Approach for Molecular Diagnosis of Andersen-Tawil Syndrome
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Syntheses of Organic Antimony Compounds as Anti-Kala-Azar. Drugs. IV
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
Syntheses of Organic Antimony Compounds as Anti-Kala-Azar Drugs. VIII
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science